US Patent Issued to CHA BIOTECH, CHA BIOLAB on June 3 for "Natural killer cells exhibiting increased anticancer activity and immunotherapeutic use thereof" (South Korean Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,936, issued on June 3, was assigned to CHA BIOTECH Co. LTD. (Seoul, South Korea) and CHA BIOLAB Co. LTD. (Seongnam-si, South Korea).

"Natural killer cells exhibiting increased anticancer activity and immunotherapeutic use thereof" was invented by Young Seok Baek (Seongnam-si, South Korea) and In Jee Lee (Seongnam-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a natural killer cell exhibiting increased anticancer activity and immunotherapeutic use thereof. According to the natural killer cell according to an aspect, a relative mean fluorescence intensity (MFI) of a specific receptor significant for cancers including gliobl...